The synthesis of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, involves a complex multi-step synthetic process. Initial routes focused on amino acid chain fragment coupling, utilizing solid-phase production methodologies to build the long peptide sequence. Subsequent investigation has explored alternative approaches, i